Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients
about
Advances in the treatment of newly diagnosed glioblastomaVaccine therapies in malignant gliomaAn update on vaccine therapy and other immunotherapeutic approaches for glioblastomaTargeting immune checkpoints in malignant gliomaCytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients.Antibody-based immunotherapy for malignant glioma.Selective inhibition of regulatory T cells by targeting the PI3K-Akt pathway.Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.The prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis.Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients.Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma.B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma PatientsVaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma.Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire.Immune-checkpoint blockade and active immunotherapy for glioma.The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma.Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?Monitoring regulatory immune responses in tumor immunotherapy clinical trials.Targeting Tregs in Malignant Brain Cancer: Overcoming IDO.Vaccine-based immunotherapy for glioblastoma.Predictive biomarkers investigated in glioblastoma.Vaccine therapies for patients with glioblastoma.Glioblastoma stem cells and stem cell-targeting immunotherapies.Glioblastoma: molecular pathways, stem cells and therapeutic targets.Brain Tumor Immunotherapy: What have We Learned so Far?Immunomonitoring in glioma immunotherapy: current status and future perspectives.Cellular immunotherapy of cancer: an overview and future directions.Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.The development of dendritic cell vaccine-based immunotherapies for glioblastoma.Dendritic cell immunotherapy for brain tumors.TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination.Trial watch: Dendritic cell-based interventions for cancer therapy.Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy.A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial.The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma.Immune Checkpoints and Innovative Therapies in Glioblastoma
P2860
Q26773514-2FA52DB4-EDF0-45C8-B9FB-5D4B7444CD2DQ26829328-06C657FD-F2F4-4388-89BE-17936F3D15DFQ27024830-BBF4D9AC-405B-43C8-A9ED-CCDBB09CCC42Q28072012-E6441E6B-C5BF-403D-8AD3-E78006BE057FQ33691858-B9290FF0-2D03-4C8F-927B-0578B6136889Q34120472-714444A3-E49B-4961-A1D7-DE0880375BA1Q34458364-3BBDFD91-C290-41EB-A48A-5B979E71959DQ36224057-AE213DF8-1967-4876-8E06-023F9B701948Q36283876-E467416F-85E4-4A34-BC00-323EE5942BBEQ36597942-30BF8F17-6080-4C8E-8EC7-F2DC57BBD15EQ36710917-16EBE80D-17C8-44D4-A090-7AC050F84DF1Q36963632-ECCC0255-4847-4183-ACB9-6DCE7DDF2684Q37014134-167C2CE6-BA0D-42D3-BA05-1F8DB99817CCQ37040756-6E66307B-0638-480E-AB28-104CDA95294FQ37420586-0992B3A1-EFA6-4921-9C33-71A354522CFBQ37471704-8AEA3CCC-9C2E-4957-92BD-604E78EF17F7Q37492175-0E4C9D4F-3F68-4B74-8174-7F71D880082CQ38062793-FBA78666-5FB5-493C-9A33-12D113E19BE2Q38105081-57DA73AC-455E-4995-BA1A-680CEFB7A408Q38110540-1E2ABDC7-2156-49DD-A445-DD7657677065Q38233114-55CB54BC-019E-4A0E-A0E1-062DBFA2F62EQ38237337-F3769A58-628B-4669-B312-C454E81B9024Q38243975-FEEB80FE-8F5C-4CF3-9CED-BCA84AC83C0DQ38355702-7E0E1F13-27F5-4DA4-B876-131404DDAAC4Q38393328-B3763D27-5F51-4D6F-83CD-A7941ACD2DE7Q38542113-02982385-D6B0-4CCD-81C2-D10CA34761BBQ38659771-CD4C6CC4-94DB-47AA-A95C-FCEA23BC873FQ38673161-43A842F8-CB33-4A19-B95A-72B8665B1829Q38743138-50546F31-15C6-436D-81E0-365807615071Q38912265-BC525CBF-5A41-4131-B36B-6F22B736E5DBQ38990679-3F3816B8-8A8D-4370-B3C5-6650635F51C6Q40875816-46425FB9-5B5E-41CC-9FA5-4B514EC8AB97Q42169344-5FADE0AB-60C3-4424-8C32-4EF673203DAAQ42867339-A3A6D0C1-D4D0-430F-AF9D-1E72CE848FF8Q46586294-83330319-8185-4BD6-9922-BFF4B987C814Q50895317-3A73D50C-C5F4-4845-AB78-419C10231257Q54980235-2D8B2989-134D-418E-9469-033E907EC70AQ55456844-607A7831-DB4A-4BD6-A669-DA713868A362Q58573409-52B46F34-565F-417B-BE1D-0BE3084348F9
P2860
Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Monitoring of regulatory T cel ...... edict survival in GBM patients
@ast
Monitoring of regulatory T cel ...... edict survival in GBM patients
@en
Monitoring of regulatory T cel ...... edict survival in GBM patients
@nl
type
label
Monitoring of regulatory T cel ...... edict survival in GBM patients
@ast
Monitoring of regulatory T cel ...... edict survival in GBM patients
@en
Monitoring of regulatory T cel ...... edict survival in GBM patients
@nl
prefLabel
Monitoring of regulatory T cel ...... edict survival in GBM patients
@ast
Monitoring of regulatory T cel ...... edict survival in GBM patients
@en
Monitoring of regulatory T cel ...... edict survival in GBM patients
@nl
P2093
P2860
P1433
P1476
Monitoring of regulatory T cel ...... edict survival in GBM patients
@en
P2093
Brendan Fong
Dominique N Lisiero
Linda M Liau
Michael Safaee
Richard Jin
Xiaoyan Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0032614
P407
P577
2012-01-01T00:00:00Z